- The anticancer drug market is the largest and is expected to continue growing. The global anticancer drug market is projected to expand from $104 billion in 2017 to $233 billion in 2020. Cancer is a disease of aging, and the global population is rapidly aging.
- Technological advancements are leading the way, with advanced diagnostics and a variety of treatments emerging.
- Of the top 10 global sales drugs, four are anticancer drugs and eight are biopharmaceuticals, leading the global pharmaceutical market.
Sales by treatment area
(billion / dollars, %)
Data: Evaluatepharma
Data: Evaluatepharma
| treatment area | 2017 sales | Expected sales in 2024 |
Average annual hematosis rate 2017-2024 |
|---|---|---|---|
| Oncology | 1,040 | 2,330 | 12.2 |
| Anti-diabetics | 461 | 595 | 3.7 |
| Autoimmune diseases (Anti-rheumatics) | 557 | 567 | 0.2 |
| Vaccines | 277 | 446 | 7.1 |
| Anti-virals | 424 | 399 | -0.9 |
| Immunosuppressants | 137 | 381 | 15.7 |
| Bronchodilators | 272 | 323 | 2.5 |
| Dermatologicals | 129 | 303 | 13.0 |
| 감각기 (Sensory Organs) | 216 | 269 | 3.2 |
| Antihypertensives | 230 | 244 | 0.8 |
Top 10 Global Pharmaceuticals
Data: Strategic Insights Into
Biopharmaceuticals Industry
Biopharmaceuticals Industry
| ranking | Product name | Sales company name | Sales (17 years) | division |
|---|---|---|---|---|
| 1 | Humira | Abbvie | 184 | monoclonal antibody |
| 2 | Revlimid | Celgene | 82 | synthetic drugs |
| 3 | Ritoxan | Roche | 75 | monoclonal antibody |
| 4 | Herceptin | Roche | 7.1 | monoclonal antibody |
| 5 | Avastin | Roche | 6.8 | monoclonal antibody |
| 6 | Remicade | Johnson & Johnson (J&J) | 5.8 | monoclonal antibody |
| 7 | Prevnar 13 | Pfizer | 5.6 | vaccine |
| 8 | Enbrel | Amgen/Pfizer | 5.4 | Fusion protein |
| 9 | Lantus | Sanofi | 5.2 | Manufactured protein |
| 10 | Lyrica | Pfizer | 5.1 | synthetic drugs |